Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Tatjana Gazibara"
Filter
Filter
Article category
Keywords
Publication year
Authors
COVID-19: Correspondence
Authors’ Reply: Vaccination, payment, and COVID-19
Jelena Dotlic, Vida Jeremic Stojkovic, Paul Cummins, Marija Milic, Tatjana Gazibara
Epidemiol Health. 2021;43:e2021100.   Published online November 23, 2021
DOI: https://doi.org/10.4178/epih.e2021100
  • 6,697 View
  • 112 Download
PDF
Abstract
Summary
COVID-19: Perspective
Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims
Jelena Dotlic, Vida Jeremic Stojkovic, Paul Cummins, Marija Milic, Tatjana Gazibara
Epidemiol Health. 2021;43:e2021081.   Published online October 6, 2021
DOI: https://doi.org/10.4178/epih.e2021081
  • 7,831 View
  • 132 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
Financial reimbursements after receiving the coronavirus disease 2019 (COVID-19) vaccine have been criticized in the literature. This strategy has been described as payment to receive the vaccines, undue inducement, and unethical. We are aware that healthcare workers who work in primary healthcare, prevention, and public health may encounter similar reasons from people who refuse vaccination against COVID-19. For this reason, we are compelled to clarify these claims and provide arguments for all healthcare workers who might be challenged by such reasoning. In this critical review, we discuss why the claims against financial incentives that have been presented in the literature are erroneous.
Summary
Key Message
When assessing the ethics of financial incentives to receive the COVID-19 vaccine, we must not confuse matters by invoking ethical concepts that are not relevant to this public health issue; calling a financial incentive an "undue inducement" is a mistake because it assumes that it would distort a potential recipient’s judgment to take on unacceptable risk, when these vaccines have already been tested and authorized by regulatory agencies, which suggests the risk is not substantial, but quite the opposite - they benefit the recipients.

Citations

Citations to this article as recorded by  
  • The effectiveness of financial incentives for COVID-19 vaccination: A systematic review
    Gabriela K. Khazanov, Rebecca Stewart, Matteo F. Pieri, Candice Huang, Christopher T. Robertson, K. Aleks Schaefer, Hansoo Ko, Jessica Fishman
    Preventive Medicine.2023; 172: 107538.     CrossRef
  • Mandatory and seasonal vaccination against COVID-19: Attitudes of the vaccinated people in Serbia
    Verica Jovanovic, Marija Milic, Jelena Dotlic, Smiljana Cvjetkovic, Vida Jeremic Stojkovic, Natasa Maksimovic, Maja Sekulic, Tatjana Gazibara
    Epidemiology and Infection.2023;[Epub]     CrossRef
  • Letter to the Editor: Financial incentives for COVID-19 vaccination
    Hyuncheol Bryant Kim
    Epidemiology and Health.2021; 43: e2021088.     CrossRef
  • Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims
    Yong-jun Choi
    Epidemiology and Health.2021; 43: e2021087.     CrossRef
  • Authors’ Reply: Vaccination, payment, and COVID-19
    Jelena Dotlic, Vida Jeremic Stojkovic, Paul Cummins, Marija Milic, Tatjana Gazibara
    Epidemiology and Health.2021; 43: e2021100.     CrossRef

Epidemiol Health : Epidemiology and Health